Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial

Introduction Migraine is a leading cause of disability and suffering worldwide. However, conventional pharmacological migraine preventive therapies are often challenging and accompanied by adverse effects. Recently, structured odour exposure has shown to successfully increase pain thresholds in pati...

Full description

Bibliographic Details
Main Authors: Hannes Wahl, Vanda Faria, Jana Dulheuer, Akshita Joshi, Anna Klimova, Antje Haehner, Gudrun Gossrau
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/7/e071443.full
_version_ 1797746047984861184
author Hannes Wahl
Vanda Faria
Jana Dulheuer
Akshita Joshi
Anna Klimova
Antje Haehner
Gudrun Gossrau
author_facet Hannes Wahl
Vanda Faria
Jana Dulheuer
Akshita Joshi
Anna Klimova
Antje Haehner
Gudrun Gossrau
author_sort Hannes Wahl
collection DOAJ
description Introduction Migraine is a leading cause of disability and suffering worldwide. However, conventional pharmacological migraine preventive therapies are often challenging and accompanied by adverse effects. Recently, structured odour exposure has shown to successfully increase pain thresholds in patients with chronic back pain. Despite the importance of the olfactory system in migraine, there are no studies investigating the impact of structured odour exposure in patients with migraine.Methods and analysis This double-blind randomised placebo-controlled trial will be conducted at the Headache Clinic of the University Pain Center at TU Dresden, Germany and aims at investigating the impact of a 12-week structured exposure to odours in women with migraine. Fifty-four women between 18 and 55 years with migraine with aura will be recruited and randomised to training with odours and odourless training. The primary outcomes are mechanical and electrical pain thresholds. Secondary outcomes comprise olfactory threshold and the number of headache days. Other exploratory measurements are headache associated pain intensity, acute analgesic intake, symptoms of anxiety and depression, and quality of life. Additionally, this protocol assesses neuroanatomical and neurofunctional changes associated with the 12-week olfactory training. Data analysis will be executed on the basis of the general linear model considering repeated measurements.Ethics and dissemination Ethical approvals were obtained from the Ethics Board of the TU Dresden (Protocol No. BO-EK-353082020). Participation will only be possible after written informed consent is provided. Findings will be disseminated through peer-reviewed journals and scientific conferences.Trial registration number DRKS00027399.
first_indexed 2024-03-12T15:31:34Z
format Article
id doaj.art-828630144504435e90a51eaadcc0017b
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-03-12T15:31:34Z
publishDate 2023-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-828630144504435e90a51eaadcc0017b2023-08-10T03:40:08ZengBMJ Publishing GroupBMJ Open2044-60552023-07-0113710.1136/bmjopen-2022-071443Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trialHannes Wahl0Vanda Faria1Jana Dulheuer2Akshita Joshi3Anna Klimova4Antje Haehner5Gudrun Gossrau6Intitute of Neuroradiology, TU Dresden Faculty of Medicine Carl Gustav Carus, Dresden, GermanyDepartment of Otorhinolaryngology, TU Dresden Faculty of Medicine Carl Gustav Carus, Dresden, GermanyDepartment of Otorhinolaryngology, TU Dresden Faculty of Medicine Carl Gustav Carus, Dresden, GermanyDepartment of Otorhinolaryngology, TU Dresden Faculty of Medicine Carl Gustav Carus, Dresden, GermanyNCT Partner Site Dresden, Institute for Medical Informatics and Biometrics, TU Dresden Faculty of Medicine Carl Gustav Carus, Dresden, GermanyDepartment of Otorhinolaryngology, TU Dresden Faculty of Medicine Carl Gustav Carus, Dresden, GermanyInterdisciplinary Pain Center, University Hospital, and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, GermanyIntroduction Migraine is a leading cause of disability and suffering worldwide. However, conventional pharmacological migraine preventive therapies are often challenging and accompanied by adverse effects. Recently, structured odour exposure has shown to successfully increase pain thresholds in patients with chronic back pain. Despite the importance of the olfactory system in migraine, there are no studies investigating the impact of structured odour exposure in patients with migraine.Methods and analysis This double-blind randomised placebo-controlled trial will be conducted at the Headache Clinic of the University Pain Center at TU Dresden, Germany and aims at investigating the impact of a 12-week structured exposure to odours in women with migraine. Fifty-four women between 18 and 55 years with migraine with aura will be recruited and randomised to training with odours and odourless training. The primary outcomes are mechanical and electrical pain thresholds. Secondary outcomes comprise olfactory threshold and the number of headache days. Other exploratory measurements are headache associated pain intensity, acute analgesic intake, symptoms of anxiety and depression, and quality of life. Additionally, this protocol assesses neuroanatomical and neurofunctional changes associated with the 12-week olfactory training. Data analysis will be executed on the basis of the general linear model considering repeated measurements.Ethics and dissemination Ethical approvals were obtained from the Ethics Board of the TU Dresden (Protocol No. BO-EK-353082020). Participation will only be possible after written informed consent is provided. Findings will be disseminated through peer-reviewed journals and scientific conferences.Trial registration number DRKS00027399.https://bmjopen.bmj.com/content/13/7/e071443.full
spellingShingle Hannes Wahl
Vanda Faria
Jana Dulheuer
Akshita Joshi
Anna Klimova
Antje Haehner
Gudrun Gossrau
Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial
BMJ Open
title Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial
title_full Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial
title_fullStr Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial
title_full_unstemmed Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial
title_short Impact of a 12-week olfactory training programme in women with migraine with aura: protocol for a double-blind, randomised, placebo-controlled trial
title_sort impact of a 12 week olfactory training programme in women with migraine with aura protocol for a double blind randomised placebo controlled trial
url https://bmjopen.bmj.com/content/13/7/e071443.full
work_keys_str_mv AT hanneswahl impactofa12weekolfactorytrainingprogrammeinwomenwithmigrainewithauraprotocolforadoubleblindrandomisedplacebocontrolledtrial
AT vandafaria impactofa12weekolfactorytrainingprogrammeinwomenwithmigrainewithauraprotocolforadoubleblindrandomisedplacebocontrolledtrial
AT janadulheuer impactofa12weekolfactorytrainingprogrammeinwomenwithmigrainewithauraprotocolforadoubleblindrandomisedplacebocontrolledtrial
AT akshitajoshi impactofa12weekolfactorytrainingprogrammeinwomenwithmigrainewithauraprotocolforadoubleblindrandomisedplacebocontrolledtrial
AT annaklimova impactofa12weekolfactorytrainingprogrammeinwomenwithmigrainewithauraprotocolforadoubleblindrandomisedplacebocontrolledtrial
AT antjehaehner impactofa12weekolfactorytrainingprogrammeinwomenwithmigrainewithauraprotocolforadoubleblindrandomisedplacebocontrolledtrial
AT gudrungossrau impactofa12weekolfactorytrainingprogrammeinwomenwithmigrainewithauraprotocolforadoubleblindrandomisedplacebocontrolledtrial